<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30061207</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>08</Month>            <Day>03</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>16</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1791-7530</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>38</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                    </PubDate>                </JournalIssue>                <Title>Anticancer research</Title>                <ISOAbbreviation>Anticancer Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.</ArticleTitle>            <Pagination>                <MedlinePgn>4435-4441</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.21873/anticanres.12745</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">GATA3, a transcription factor expressed in luminal breast epithelial cells, is required for mammary gland development. Heterozygous GATA3 mutations occur in up to 15% of estrogen receptor (ER)-positive breast tumors and have been proposed to be null alleles resulting in haploinsufficiency; however, the mutation spectrum of GATA3 in breast cancer is in sharp contrast to that found in HDR syndrome, a true GATA3 haploinsufficiency disease.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Transgenic mice, 3D cultures and xenografts were used to examine the effect of mutant GATA3 expression on mammary cell proliferation.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mutant GATA3 accelerated tumor growth of ZR751 cell xenografts and promoted precocious lobuloalveolar development in transgenic mouse mammary glands.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">GATA3 mutations, recently observed in breast cancer, encode active transcription factors, which elicit proliferative phenotypes in normal mammary epithelium and promote the growth of ER-positive breast cancer cell lines.</AbstractText>                <CopyrightInformation>CopyrightÂ© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Emmanuel</LastName>                    <ForeName>Natasha</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lofgren</LastName>                    <ForeName>Kristopher A</ForeName>                    <Initials>KA</Initials>                    <AffiliationInfo>                        <Affiliation>Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peterson</LastName>                    <ForeName>Esther A</ForeName>                    <Initials>EA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Meier</LastName>                    <ForeName>David R</ForeName>                    <Initials>DR</Initials>                    <AffiliationInfo>                        <Affiliation>Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jung</LastName>                    <ForeName>Eric H</ForeName>                    <Initials>EH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kenny</LastName>                    <ForeName>Paraic A</ForeName>                    <Initials>PA</Initials>                    <AffiliationInfo>                        <Affiliation>Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, WI, U.S.A. pakenny@gundersenhealth.org.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>K12 GM102779</GrantID>                    <Acronym>GM</Acronym>                    <Agency>NIGMS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Anticancer Res</MedlineTA>            <NlmUniqueID>8102988</NlmUniqueID>            <ISSNLinking>0250-7005</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D050990">GATA3 Transcription Factor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C494749">GATA3 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 1993 Jul;13(7):4011-22</RefSource>                <PMID Version="1">8321208</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 1993 Jul;13(7):3999-4010</RefSource>                <PMID Version="1">8321207</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2007 Jul 1;67(13):6477-83</RefSource>                <PMID Version="1">17616709</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2001 Aug 15;61(16):5979-84</RefSource>                <PMID Version="1">11507038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2004 Oct 7;23(46):7669-78</RefSource>                <PMID Version="1">15361840</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2000 Jul 27;406(6794):419-22</RefSource>                <PMID Version="1">10935639</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Reprod. 2001 Sep;65(3):680-8</RefSource>                <PMID Version="1">11514328</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Jun 10;486(7403):353-60</RefSource>                <PMID Version="1">22722193</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Horm Cancer. 2013 Jun;4(3):123-39</RefSource>                <PMID Version="1">23435732</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Methods. 2007 Apr;4(4):359-65</RefSource>                <PMID Version="1">17396127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Endocrinol. 1988 Feb;2(2):143-7</RefSource>                <PMID Version="1">2840570</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Apr 22;14:278</RefSource>                <PMID Version="1">24758297</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2011 Nov;31(22):4609-22</RefSource>                <PMID Version="1">21930782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Protoc Neurosci. 2009 Jul;Appendix 4:Appendix 4I</RefSource>                <PMID Version="1">19575469</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>                <PMID Version="1">23000897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 May 16;486(7403):400-4</RefSource>                <PMID Version="1">22722201</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):365-73</RefSource>                <PMID Version="1">18268121</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2007 Feb;9(2):201-9</RefSource>                <PMID Version="1">17187062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Jan;119(2):491-6</RefSource>                <PMID Version="1">19189213</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):698-702</RefSource>                <PMID Version="1">1846961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Oct 20;8(61):103415-103427</RefSource>                <PMID Version="1">29262572</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biotechniques. 2002 Apr;32(4):830, 832, 834 passim</RefSource>                <PMID Version="1">11962605</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2010 Jan;222(1):42-9</RefSource>                <PMID Version="1">19798694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2006 Dec 1;127(5):1041-55</RefSource>                <PMID Version="1">17129787</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004848" MajorTopicYN="N">Epithelium</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D050990" MajorTopicYN="N">GATA3 Transcription Factor</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">GATA3</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">mammary gland biology</Keyword>            <Keyword MajorTopicYN="N">transcription factor</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30061207</ArticleId>            <ArticleId IdType="pii">38/8/4435</ArticleId>            <ArticleId IdType="doi">10.21873/anticanres.12745</ArticleId>            <ArticleId IdType="pmc">PMC6092927</ArticleId>            <ArticleId IdType="mid">NIHMS984458</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>